Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Compound Dan Zhi tablet (DZT) is a commonly used traditional Chinese medicine formula. It has been used for the treatment of ischemic stroke for many years in clinical. However, its pharmacological mechanism is unclear.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Purpose</h3><p>The aim of the current study was to understand the protective effects and underlying mechanisms of DZT on ischemic stroke.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Fifteen representative chemical markers in DZT were determined by ultra-performance liquid chromatography coupled with tandem quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS). The protective effect of DZT against ischemic stroke was studied in a rat model of middle cerebral artery occlusion (MCAO), and the mechanism was further explored through a combination of network pharmacology and experimental verification.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Quantitative analysis showed that the contents of phenolic acids, furan sulfonic acids, tanshinones, flavonoids, saponins and phthalides in DZT were calculated as 7.47, 0.788, 0.627, 0.531 and 0.256 mg/g, respectively. Phenolic acids were the most abundant constituents. Orally administered DZT (1.701 g kg<sup>−1</sup>) significantly alleviated the infarct size and neurological scores in MCAO rats. The network analysis predicted that 53 absorbed active compounds in DZT-treated plasma targeted 189 proteins and 47 pathways. Ten pathways were associated with anti-platelet activity. In further experiments, DZT (0.4 and 0.8 mg mL<sup>−1</sup>) markedly inhibited <em>in vitro</em> prostaglandin G/H synthase 1 (PTGS1) activity. DZT (0.4 and 0.8 mg mL<sup>−1</sup>) significantly inhibited <em>in vitro</em> platelet aggregation in response to ADP or AA. DZT (113 and 226 mg kg<sup>−1</sup>, p.o.) also produced a marked inhibition of ADP- or AA-induced <em>ex vivo</em> platelet aggregation with a short duration of action. DZT decreased the level of thromboxane A<sub>2</sub> (TXA<sub>2</sub>) in MCAO rats. In the carrageenan-induced tail thrombosis model and ADP-induced acute pulmonary thromboembolism mice model, DZT (113 and 226 mg kg<sup>−1</sup>, p.o.) prevented thrombus formation. Importantly, DZT (113 and 226 mg kg<sup>−1</sup>, p.o.) exhibited a low bleeding liability.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>DZT protected against cerebral ischemic injury. The inhibition of TXA<sub>2</sub> level, platelet aggregation and thrombosis formation might involve in the protective mechanism.</p>

Inhibition of PAI-1 Activity by Toddalolactone as a Mechanism for Promoting Blood Circulation and Removing Stasis by Chinese Herb Zanthoxylum nitidum var. tomentosum

Identification of Cryptotanshinone from Tongmai to Inhibit Thrombosis in Zebrafish Via Regulating Oxidative Stress and Coagulation Cascade.

Theaflavin: a Natural Candidate to Restrain Thrombosis

Exploring the molecular mechanism of Toddalia asiatica (L.) lam on the treatment of thrombosis based on zebrafish models, network pharmacology and experimental verification

Studies of the Synergistic Actions of Three Herbs in Tong-Mai Formula

L-Tetrahydropalmatine, An Active Component Of Corydalis Yanhusuo W.T. Wang, Protects Against Myocardial Ischaemia-Reperfusion Injury In Rats

Bioactivity-Guided Fractionation of the Traditional Chinese Medicine Resina Draconis Reveals Loureirin B as a PAI-1 Inhibitor

Compound Dan Zhi tablet attenuates experimental ischemic stroke via inhibiting platelet activation and thrombus formation

Modulation Of Platelet Activation And Thrombus Formation Using A Pan-Pi3k Inhibitor S14161

Integrated pharmacokinetics and pharmacometabolomics to reveal the synergistic mechanism of a multicomponent Chinese patent medicine, Mailuo Shutong pills against thromboangiitis obliterans

CF–PK–PD Analysis of Natural Hemostatic Compounds from Toddalia Asiatica (linn) Lam Root Bark in Rats

The Therapeutic Potential of Four Main Compounds of Zanthoxylum nitidum (Roxb.) DC: A Comprehensive Study on Biological Processes, Anti-Inflammatory Effects, and Myocardial Toxicity

Effective components and mechanism analysis of anti-platelet aggregation effect of Justicia procumbens L.

Toddalolactone protects against osteoarthritis by ameliorating chondrocyte inflammation and suppressing osteoclastogenesis

Thrombosis inhibited by Corydalis decumbens through regulating PI3K-Akt pathway

Xuefu Zhuyu decoction alleviates deep vein thrombosis through inhibiting the activation of platelets and neutrophils via sirtuin 1/nuclear factor kappa-B pathway

Synergistic Effects of Cryptotanshinone and Senkyunolide I in Guanxinning Tablet Against Endogenous Thrombus Formation in Zebrafish

Mailuoning oral liquid ameliorates vasculitis in thromboangiitis obliterans rats via inactivating cGAS-STING-IRF3 and TLR4-MAPKs/NF-κB signaling pathways

Extract from Rostellularia procumbens (L.) Nees Inhibits Thrombosis and Platelet Aggregation by Regulating Integrin β 3 and MAPK Pathways

Alleviation of endothelial dysfunction of Pheretima guillemi (Michaelsen)-derived protein DPf3 in ponatinib-induced thrombotic zebrafish and mechanisms explored through ox-LDL-induced HUVECs and TMT-based proteomics

Integrating UPLC-Q-TOF-MS and Network Pharmacology to Explore the Potential Mechanisms of Paeonia lactiflora Pall. in the Treatment of Blood Stasis Syndrome